n-methyladenosine has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, W; Li, Q; Liu, P; Ma, Z; Zuo, Y | 1 |
| Jiang, L; Jiao, J; Luo, Y | 1 |
2 other study(ies) available for n-methyladenosine and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Topics: Adenosine; Aged; Carcinogenesis; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Cell Cycle Proteins; Cell Line, Tumor; Cell Transformation, Neoplastic; China; Female; Gene Expression; Gene Expression Profiling; HeLa Cells; Humans; Methylation; Methyltransferases; Middle Aged; RNA Splicing Factors; RNA, Messenger; Transcriptome | 2020 |
N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex alpha Subunits; Adenosine; Angiotensin-Converting Enzyme 2; Carcinoma, Ovarian Epithelial; CD79 Antigens; Cell Cycle Proteins; Female; Filaggrin Proteins; GTP Phosphohydrolases; Histone Deacetylase 1; Homeodomain Proteins; Humans; Membrane Proteins; Ovarian Neoplasms; Prognosis; Proportional Hazards Models; Receptors, G-Protein-Coupled; Repressor Proteins; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA, Messenger; Sodium-Bicarbonate Symporters; Survival Rate; Transcription Factors; Transcriptome | 2021 |